Latorre et al. employed albumin-stabilized gold nanoclusters loaded with AZD8055, an mTOR kinase inhibitor that exerts its oncolytic effect via the PI3K/AKT/mTOR pathway for the treatment of uveal melanoma. Here, ALB is linked to uveal melanoma.